You are here

  • Home
  • Online First
  • Should gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy?

Article Text

Article menu

other Versions

Download PDFPDF
Should gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy?
  1. Rajiv Sinha (rajivsinha_in{at}yahoo.com)
  1. British Columbia's Children's Hospital, Canada
    1. Janis M Dionne
    1. British Columbia's Children's Hospital, Canada

      Abstract

      1) Young women suffering from SLE treated with CYC have a high risk of ovarian failure. [Grade C]

      2) GnRH is a promising option for ovarian preservation in SLE but should currently be regarded as an experimental therapy.

      https://doi.org/10.1136/adc.2007.131334

      Statistics from Altmetric.com

        Request Permissions

        If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.